Martin Dreyling

25PUBLICATIONS

274CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyHaematologyTumour immunologyHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jul 14, 2026

Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.

|Jul 07, 2026

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

|Jul 01, 2026

Clinical decision support in hematological malignancies using a case-grounded AI agent.

|Jun 23, 2026

Loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma.

|Oct 29, 2025

Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.

Tom van Meerten, Marie José Kersten, Gloria Iacoboni

|May 01, 2025

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.

Michael Wang, David Salek, David Belada

Pageof 5

Frequent Collaborators

Eva Hoster

Gilles Salles

David W Scott

Pier-Luigi Zinzani

Christiane Pott

Elias Campo

Catherine Thieblemont

3 joint publications

John F Seymour

3 joint publications

Wolfram Klapper

3 joint publications

Linmiao Jiang

Frequent Collaborators

Eva Hoster

Gilles Salles

David W Scott

Pier-Luigi Zinzani